BDBM573855 2-amino-9-[(5S,7R,8R,12aR,14R,15S,15aS)-14- (6-amino-9H-purin-9-yl)-2,10-dihydroxy-15- methyl-2,10-dioxidooctahydro-12H-5,8- methanofuro[3,2-l][1,3,6,9,11,2,10] pentaoxadiphosphacyclotetradecin-7-yl]-1,9- dihydro-6H-purin-6-one::US11453697, Example 19

SMILES C[C@H]1[C@@H]2OP(O)(=O)OC[C@@H]3C[C@@H](OP(O)(=O)OC[C@H]2O[C@H]1n1cnc2c(N)ncnc12)[C@@H](O3)n1cnc2c1nc(N)[nH]c2=O

InChI Key InChIKey=PHCHUTVZHWWALH-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 573855   

LigandPNGBDBM573855(US11453697, Example 19 | 2-amino-9-[(5S,7R,8R,12aR...)
Affinity DataEC50:  173nMAssay Description:The compounds were serially titrated by the Hamilton STARPlus CORE in a 96-well plate (Greiner, #651201) using a 1:3 ten-point dose response format. ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
Go to US Patent